[go: up one dir, main page]

AU2003239763A1 - Hyaluronate lyase-containing agent for treating acute myocardial infarction or symptoms thereof and for the treatment of postinfarction myocarditis and myocardial ischaemia - Google Patents

Hyaluronate lyase-containing agent for treating acute myocardial infarction or symptoms thereof and for the treatment of postinfarction myocarditis and myocardial ischaemia

Info

Publication number
AU2003239763A1
AU2003239763A1 AU2003239763A AU2003239763A AU2003239763A1 AU 2003239763 A1 AU2003239763 A1 AU 2003239763A1 AU 2003239763 A AU2003239763 A AU 2003239763A AU 2003239763 A AU2003239763 A AU 2003239763A AU 2003239763 A1 AU2003239763 A1 AU 2003239763A1
Authority
AU
Australia
Prior art keywords
postinfarction
myocarditis
symptoms
treatment
treating acute
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003239763A
Other versions
AU2003239763A8 (en
Inventor
Peter-Jurgen Muller
Jorg-Hermann Ozegowski
Michael Wolfram
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HANS-KNOLL-INSTITUT fur NATURSTOFF-FORSCHUNG EV
Friedrich Schiller Universtaet Jena FSU
Original Assignee
HANS KNOLL INST fur NATURSTOFF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HANS KNOLL INST fur NATURSTOFF filed Critical HANS KNOLL INST fur NATURSTOFF
Publication of AU2003239763A8 publication Critical patent/AU2003239763A8/en
Publication of AU2003239763A1 publication Critical patent/AU2003239763A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003239763A 2003-05-27 2003-05-27 Hyaluronate lyase-containing agent for treating acute myocardial infarction or symptoms thereof and for the treatment of postinfarction myocarditis and myocardial ischaemia Abandoned AU2003239763A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/DE2003/001789 WO2004110479A1 (en) 2003-05-27 2003-05-27 Hyaluronate lyase-containing agent for treating acute myocardial infarction or symptoms thereof and for the treatment of postinfarction myocarditis and myocardial ischaemia

Publications (2)

Publication Number Publication Date
AU2003239763A8 AU2003239763A8 (en) 2005-01-04
AU2003239763A1 true AU2003239763A1 (en) 2005-01-04

Family

ID=33546407

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003239763A Abandoned AU2003239763A1 (en) 2003-05-27 2003-05-27 Hyaluronate lyase-containing agent for treating acute myocardial infarction or symptoms thereof and for the treatment of postinfarction myocarditis and myocardial ischaemia

Country Status (2)

Country Link
AU (1) AU2003239763A1 (en)
WO (1) WO2004110479A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007031417A1 (en) 2007-07-04 2009-01-08 Friedrich-Schiller-Universität Jena Hyaluronate lyase with a histidine tag e.g. useful in pharmaceutical formulations and medical products
RU2543356C1 (en) * 2014-03-03 2015-02-27 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИ КПССЗ" СО РАМН) Method for prediction of early post-infarction angina in patients with acute st-elevation myocardial infarction across staying in hospital

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19982882D2 (en) * 1998-12-23 2001-10-04 Id Pharma Gmbh Pharmaceutical formulation containing a hyaluronic acid-cleaving enzyme of microbial origin
CN1355850A (en) * 1999-06-12 2002-06-26 默克专利股份有限公司 Hyaluronidase from Leech Manila, method for isolation, purification and recombinant production
DE10103271A1 (en) * 2001-01-23 2002-07-25 Knoell Hans Forschung Ev Pharmaceutical formulation containing hyaluronatlyase, useful for softening of connective tissue in medical and cosmetic treatment, especially in shape correction

Also Published As

Publication number Publication date
AU2003239763A8 (en) 2005-01-04
WO2004110479A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
AP2008004509A0 (en) Treatment of cellulosic material and enzymes useful therein
EP1628530B8 (en) Methods and compositions for the prevention and treatment of sepsis
AU2003237367A1 (en) Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
WO2006015263A3 (en) Lonidamine analogs
ZA200507996B (en) Use of an IBAT inhibitor for the treatment or prophylaxis of constipation
AU2003290605A8 (en) Compositions and methods for the diagnosis and treatment of sepsis
AU2003212634A8 (en) Compounds useful in the treatment of cancer
ZA200707472B (en) Diosmetin derivatives for the treatment and prevention of thrombotic pathologies
AU2003214148A8 (en) Use of context identifiers in cache memory
AU2003247784A8 (en) Compositions and methods for treatment and detection of multiple cancers
EP1579010A4 (en) Susceptibility gene for myocardial infarction; methods of treatment
PL1896502T3 (en) Treatment of fungal and/or protist infections
PL1653982T3 (en) Treatment of halitosis
AU2003239763A1 (en) Hyaluronate lyase-containing agent for treating acute myocardial infarction or symptoms thereof and for the treatment of postinfarction myocarditis and myocardial ischaemia
AU2003220026A1 (en) Methods and compositions for the treatment of ischemia
AU2003297401A8 (en) Surface treatment of polyacetal articles
ZA200606268B (en) Treatment of coronary or peripheral ischemia
HUP0300990D0 (en) Synergistic combination for the prophylaxis and treatment of diabetes
AU2003255844A1 (en) Five-membered heterocyclic compounds in the treatment of chronic and acute pain
SI1680405T1 (en) Bengamide derivatives and use thereof for the treatment of cancer
GB2428007B (en) Composition for preventing and treating myocardial infarction
GB0317500D0 (en) Treatment of bph
AU2003300651A1 (en) Use of prebiotics for preventing or treating oxidation stress
EP1487448A4 (en) Treatment of effect of chemicals with their ultradilute stereoisomers
AU2003216954A1 (en) Treatment of dependence and dependence related withdrawal symptoms

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 19, NO 7, PAGE(S) 418 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME HANS-KNOLL-INSTITUT FUR NATURSTOFF-FORSCHUNG E.V., APPLICATION NO. 2003239763, UNDER INID (71) CORRECT THE NAME TO READ FRIEDRICH-SCHILLERUNIVERSIT# T JENA; HANS-KNOLL-INSTITUT FUR NATURSTOFF-FORSCHUNG E.V.

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase